182 related articles for article (PubMed ID: 37733672)
1. Peptide immunization against the C-terminal of alpha-synuclein reduces locomotor activity in mice overexpressing alpha-synuclein.
Chiu YS; Wu KJ; Yu SJ; Wu KL; Wang YS; Lin J; Chu CY; Chen S; Chen H; Hsu SC; Wang Y; Chen YH
PLoS One; 2023; 18(9):e0291927. PubMed ID: 37733672
[TBL] [Abstract][Full Text] [Related]
2. Administration of AAV-Alpha Synuclein NAC Antibody Improves Locomotor Behavior in Rats Overexpressing Alpha Synuclein.
Chen YH; Wu KJ; Hsieh W; Harvey BK; Hoffer BJ; Wang Y; Yu SJ
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34205689
[TBL] [Abstract][Full Text] [Related]
3. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
[TBL] [Abstract][Full Text] [Related]
4. Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice.
Cai W; Feng D; Schwarzschild MA; McLean PJ; Chen X
EBioMedicine; 2018 Mar; 29():13-22. PubMed ID: 29433982
[TBL] [Abstract][Full Text] [Related]
5. Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.
García-Revilla J; Boza-Serrano A; Jin Y; Vadukul DM; Soldán-Hidalgo J; Camprubí-Ferrer L; García-Cruzado M; Martinsson I; Klementieva O; Ruiz R; Aprile FA; Deierborg T; Venero JL
Acta Neuropathol; 2023 Jul; 146(1):51-75. PubMed ID: 37202527
[TBL] [Abstract][Full Text] [Related]
6. LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss.
Ho DH; Nam D; Seo M; Park SW; Seol W; Son I
Cells; 2022 Mar; 11(5):. PubMed ID: 35269482
[TBL] [Abstract][Full Text] [Related]
7. Immunization with α-synuclein/Grp94 reshapes peripheral immunity and suppresses microgliosis in a chronic Parkinsonism model.
Villadiego J; Labrador-Garrido A; Franco JM; Leal-Lasarte M; De Genst EJ; Dobson CM; Pozo D; Toledo-Aral JJ; Roodveldt C
Glia; 2018 Jan; 66(1):191-205. PubMed ID: 29024008
[TBL] [Abstract][Full Text] [Related]
8. Binding Stability of Antibody-α-Synuclein Complexes Predicts the Protective Efficacy of Anti-α-synuclein Antibodies.
Höllerhage M; Wolff A; Chakroun T; Evsyukov V; Duan L; Chua OW; Tang Q; Koeglsperger T; Höglinger GU
Mol Neurobiol; 2022 Jul; 59(7):3980-3995. PubMed ID: 35460053
[TBL] [Abstract][Full Text] [Related]
9. Transmissible α-synuclein seeding activity in brain and stomach of patients with Parkinson's disease.
Thomzig A; Wagenführ K; Pinder P; Joncic M; Schulz-Schaeffer WJ; Beekes M
Acta Neuropathol; 2021 Jun; 141(6):861-879. PubMed ID: 33895878
[TBL] [Abstract][Full Text] [Related]
10. Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.
Maki RA; Holzer M; Motamedchaboki K; Malle E; Masliah E; Marsche G; Reynolds WF
Free Radic Biol Med; 2019 Sep; 141():115-140. PubMed ID: 31175983
[TBL] [Abstract][Full Text] [Related]
11. Endothelial LRP1-ICD Accelerates Cognition-Associated Alpha-Synuclein Pathology and Neurodegeneration through PARP1 Activation in a Mouse Model of Parkinson's Disease.
Huang R; Gao Y; Duan Q; Zhang Q; He P; Chen J; Ma G; Wang L; Zhang Y; Nie K; Wang L
Mol Neurobiol; 2023 Feb; 60(2):979-1003. PubMed ID: 36394710
[TBL] [Abstract][Full Text] [Related]
12. Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression.
Schlichtmann BW; Palanisamy BN; Malovic E; Nethi SK; Padhi P; Hepker M; Wurtz J; John M; Ban B; Anantharam V; Kanthasamy AG; Narasimhan B; Mallapragada SK
Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627268
[TBL] [Abstract][Full Text] [Related]
13. α-Synuclein decoy peptide protects mice against α-synuclein-induced memory loss.
Guo Q; Kawahata I; Jia W; Wang H; Cheng A; Yabuki Y; Shioda N; Fukunaga K
CNS Neurosci Ther; 2023 Jun; 29(6):1547-1560. PubMed ID: 36786129
[TBL] [Abstract][Full Text] [Related]
14. A Single Chain Fragment Variant Binding Misfolded Alpha-Synuclein Exhibits Neuroprotective and Antigen-Specific Anti-Inflammatory Properties.
Fassler M; Benaim C; George J
Cells; 2022 Nov; 11(23):. PubMed ID: 36497081
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of α-Synuclein Protein Levels by an Intracellular Single-Chain Antibody.
Chen YH; Yu SJ; Wu KJ; Wang YS; Tsai HM; Liao LW; Chen S; Hsieh W; Chen H; Hsu SC; Chen ML; Hoffer BJ; Wang Y
J Parkinsons Dis; 2020; 10(2):573-590. PubMed ID: 32176654
[TBL] [Abstract][Full Text] [Related]
16. Gangliosides, α-Synuclein, and Parkinson's Disease.
Ledeen RW; Wu G
Prog Mol Biol Transl Sci; 2018; 156():435-454. PubMed ID: 29747823
[TBL] [Abstract][Full Text] [Related]
17. Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model.
Eteläinen TS; Kilpeläinen TP; Ignatius A; Auno S; De Lorenzo F; Uhari-Väänänen JK; Julku UH; Myöhänen TT
Neuropharmacology; 2022 Nov; 218():109213. PubMed ID: 35964686
[TBL] [Abstract][Full Text] [Related]
18. STING mediates neurodegeneration and neuroinflammation in nigrostriatal α-synucleinopathy.
Hinkle JT; Patel J; Panicker N; Karuppagounder SS; Biswas D; Belingon B; Chen R; Brahmachari S; Pletnikova O; Troncoso JC; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2118819119. PubMed ID: 35394877
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology of α-synuclein in Parkinson's disease.
Choong CJ; Mochizuki H
Neuropathology; 2022 Apr; 42(2):93-103. PubMed ID: 35362115
[TBL] [Abstract][Full Text] [Related]
20. Microglial inhibition alleviates alpha-synuclein propagation and neurodegeneration in Parkinson's disease mouse model.
Thi Lai T; Kim YE; Nguyen LTN; Thi Nguyen T; Kwak IH; Richter F; Kim YJ; Ma HI
NPJ Parkinsons Dis; 2024 Feb; 10(1):32. PubMed ID: 38302446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
